Share the post "Delivery Share breakouts today insights on 28-Aug-2024"
Company Name | Initial Breakout Date | Initial Delivery Value | Final Breakout Date | Final Delivery Value | Delivery (In %) | Breakout | Current Price | High Price(52 W) | Low price (52 W) | Marketcap |
---|---|---|---|---|---|---|---|---|---|---|
Esab India | May 16, 2024 | 155,561.80K | 28-Aug-2024 | 243,219.45K | 93.52% | 1 Year | Rs6162.6 | Rs6991.15 | Rs4618.65 | 9,486.10 Cr |
Uniphos Enterprises | Mar 05, 2024 | 8,464.15K | 28-Aug-2024 | 8,931.00K | 60.36% | 1 Year | Rs170.15 | Rs183.75 | Rs127 | 1,183.32 Cr |
Ucal | Aug 27, 2024 | 93,746.40K | 28-Aug-2024 | 155,964.89K | 25.17% | 5 Years | Rs209.4 | Rs229.9 | Rs126 | 463.06 Cr |
Esab India demonstrated diverse delivery trends during the 1 Year breakout period. Starting at 155,561.80K units on May 16, 2024, the delivery volume escalated to 243,219.45K units by 28-Aug-2024, marking a delivery rate of 93.52%. Throughout this breakout, the stock’s price fluctuated between a low of Rs6112.1 and a high of Rs6231, with the current price resting at Rs6162.6. The company’s market capitalization is currently valued at 9,486.10 crores.
Uniphos Enterprises demonstrated diverse delivery trends during the 1 Year breakout period. Starting at 8,464.15K units on Mar 05, 2024, the delivery volume escalated to 8,931.00K units by 28-Aug-2024, marking a delivery rate of 60.36%. Throughout this breakout, the stock’s price fluctuated between a low of Rs169 and a high of Rs172.95, with the current price resting at Rs170.15. The company’s market capitalization is currently valued at 1,183.32 crores.
Ucal demonstrated diverse delivery trends during the 5 Years breakout period. Starting at 93,746.40K units on Aug 27, 2024, the delivery volume escalated to 155,964.89K units by 28-Aug-2024, marking a delivery rate of 25.17%. Throughout this breakout, the stock’s price fluctuated between a low of Rs205 and a high of Rs229.9, with the current price resting at Rs209.4. The company’s market capitalization is currently valued at 463.06 crores.
Esab India Limited
3,296.10
Net Sales
444.50
Net Profit
3,308.20
Total Income
2,709.80
Expenditure
6,189
Current Price
9,525
Market Cap
In Esab India Limited's recent financial report, the data highlights a robust performance. Net sales reached ₹3,296.10 million, with total income of ₹3,308.20 million. The expenditure was ₹2,709.80 million, leading to a net profit of ₹444.50 million. Earnings per Share (EPS) for continuing operations were reported at ₹28.88. The financial overview also includes other income of ₹12.10 million, finance costs of ₹1.10 million, and employee benefit expenses totaling ₹282.70 million. Depreciation and amortization expenses were ₹33.30 million. Current and deferred taxes were recorded at ₹151.50 million and ₹2.40 million, respectively. The total comprehensive income for the period was ₹444.50 million, and other comprehensive income net of taxes was ₹0.00 million.
With a market capitalization of ₹9,525 crore, the company’s stock is currently priced at ₹6,189. The historical trading range of the stock is ₹6,999 / 4,619. The P/E ratio is remarkably high at 177, suggesting a significant valuation. The book value stands at ₹67.6, and the dividend yield is 1.39%. The Return on Capital Employed (ROCE) is 90.8%, and the Return on Equity (ROE) is 59.3%. The debt-to-equity ratio is very low at 0.00, though the company shows a negative net cash flow of ₹-5.23 crore. The Piotroski score is 7.00, with the Graham Number pegged at ₹230. The Price-to-Book (P/B) ratio of 91.6 highlights a premium valuation.
Uniphos Enterprises Limited
30.26
Net Sales
-1.47
Net Profit
38.19
Total Income
39.66
Expenditure
173
Current Price
1,205
Market Cap
The financial snapshot for Uniphos Enterprises Limited reveals a noteworthy performance this quarter. Net sales amounted to ₹30.26 million and total income was ₹38.19 million. The company's expenditure was ₹39.66 million, leading to a net profit of ₹-1.47 million. Earnings per Share (EPS) for continuing operations were ₹0.00. The report also highlights other income of ₹7.93 million, finance costs of ₹0.00 million, and employee benefit expenses of ₹2.99 million. Depreciation and amortization costs were ₹1.89 million, while current and deferred taxes were ₹0.00 million and ₹0.00 million, respectively. The total comprehensive income for the period stood at ₹4,014.58 million, with other comprehensive income net of taxes at ₹4,016.06 million.
Currently valued at ₹1,205 crore, the company's stock price is ₹173. It has seen a price range of ₹184 / 127 over time. The stock's Price-to-Earnings (P/E) ratio is notably high at 31.2, implying a strong valuation. The book value per share is ₹298 and the dividend yield is 3.75%. ROCE is recorded at 1.54%, and ROE stands at 1.52%. The company maintains a very low debt-to-equity ratio of 0.00, though it has a negative net cash flow of ₹1.49 crore. The Piotroski score of 6.00 and the Graham Number of ₹193 suggest some caution, while the Price-to-Book (P/B) ratio of 0.58 reflects a premium valuation.
UCAL LIMITED
1,870.73
Net Sales
-25.13
Net Profit
1,892.92
Total Income
1,909.30
Expenditure
195
Current Price
431
Market Cap
The financial snapshot for UCAL LIMITED reveals a noteworthy performance this quarter. Net sales amounted to ₹1,870.73 million and total income was ₹1,892.92 million. The company's expenditure was ₹1,909.30 million, leading to a net profit of ₹-25.13 million. Earnings per Share (EPS) for continuing operations were ₹-1.14. The report also highlights other income of ₹22.19 million, finance costs of ₹86.78 million, and employee benefit expenses of ₹440.51 million. Depreciation and amortization costs were ₹101.03 million, while current and deferred taxes were ₹1.80 million and ₹6.96 million, respectively. The total comprehensive income for the period stood at ₹-24.46 million, with other comprehensive income net of taxes at ₹0.68 million.
Valued at ₹431 crore, the company's stock trades at ₹195, with historical highs and lows of ₹230 / 126. The P/E ratio of reflects a high stock valuation. The book value is ₹168, and the dividend yield is 1.03%. ROCE is at 2.50%, and ROE is -6.64%. The company’s minimal debt-to-equity ratio of 0.72 contrasts with its negative net cash flow of ₹4.41 crore. The Piotroski score is 4.00, and the Graham Number of ₹ provides insight into the stock’s valuation. The Price-to-Book (P/B) ratio of 1.16 indicates a premium valuation.